LONDON, Oct. 30, 2014 /PRNewswire/ -- The global meningococcal vaccines market is studied on the basis of vaccine types such as polysaccharide, conjugate and combination vaccines. The vaccine types are further segmented into different brands. The report also highlights and analyzes various brands under pipeline segment, namely, Bexsero, MnB rLP2806 and NmVac-4DT. A detailed market analysis and forecast for these segments has been provided in this study, in terms of revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each meningococcal vaccine segment and brand for the forecast period 2013 to 2019, while market size estimations have been made considering 2011 and 2012 as the base years.
In terms of geographical distribution, the global meningococcal vaccines market has been classified into four major geographical areas, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The current and future market sizes (in terms of USD million) of the above regional markets have been provided in the report for the period 2011 to 2019 with their growth rate (%) for the period 2013 to 2019. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and flourish in the global meningococcal vaccines market.
The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints and opportunities that influence the current and future status of this industry. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global meningococcal vaccines market.
The report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include Sanofi S.A., Novartis International AG, GlaxoSmithKline plc, Pfizer, Inc., Serum Institute of India, Ltd., JN-International Medical Corporation, Nuron Biotech, Baxter International and Biomed Pvt. Ltd.
The global meningococcal vaccines market is segmented as follow:
Meningococcal Vaccines Market, by Type Polysaccharide Vaccines, by Brand
Menomune
Mencevax
NmVac4
Others
Quadri Meningo
Bi Meningo
Conjugate Vaccines, by Brand
Menactra
Menveo
NeisVac-C
Nimenrix
Meningitec
Menjugate
MenAfriVac
Combination Vaccines, by Brand
MenHibrix
Menitorix
Pipeline Vaccines, by Brand
Bexsero
MnB rLP2806
NmVac4-DT
Meningococcal Vaccines Market, by Geography North America
Europe
Asia-Pacific
Rest of the World
Download the full report: https://www.reportbuyer.com/product/2116909/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
SOURCE ReportBuyer
Advertisement
In terms of geographical distribution, the global meningococcal vaccines market has been classified into four major geographical areas, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The current and future market sizes (in terms of USD million) of the above regional markets have been provided in the report for the period 2011 to 2019 with their growth rate (%) for the period 2013 to 2019. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and flourish in the global meningococcal vaccines market.
Advertisement
The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints and opportunities that influence the current and future status of this industry. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global meningococcal vaccines market.
The report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include Sanofi S.A., Novartis International AG, GlaxoSmithKline plc, Pfizer, Inc., Serum Institute of India, Ltd., JN-International Medical Corporation, Nuron Biotech, Baxter International and Biomed Pvt. Ltd.
The global meningococcal vaccines market is segmented as follow:
Meningococcal Vaccines Market, by Type Polysaccharide Vaccines, by Brand
Menomune
Mencevax
NmVac4
Others
Quadri Meningo
Bi Meningo
Conjugate Vaccines, by Brand
Menactra
Menveo
NeisVac-C
Nimenrix
Meningitec
Menjugate
MenAfriVac
Combination Vaccines, by Brand
MenHibrix
Menitorix
Pipeline Vaccines, by Brand
Bexsero
MnB rLP2806
NmVac4-DT
Meningococcal Vaccines Market, by Geography North America
Europe
Asia-Pacific
Rest of the World
Download the full report: https://www.reportbuyer.com/product/2116909/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
SOURCE ReportBuyer
